Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants

Brachytherapy

Volumn 10, Issue 4, 2011, Pages 275-285

  Usmani, Nawaid ^a,b   Chng, Nick ^c   Spadinger, Ingrid ^c   Morris, W James ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Gold fiducial markers; Migration; Prostate brachytherapy; Stranded sources

Indexed keywords

ANTIANDROGEN; GOLD; IODINE 125;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CLINICAL ARTICLE; COMPUTER PROGRAM; EDEMA; FIDUCIAL MARKER; HUMAN; HUMAN TISSUE; IMPLANTATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION ABSORPTION;

AGED; FIDUCIAL MARKERS; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; PROSTHESIS FAILURE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79956213141     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2010.10.001     Document Type: Article

References (26)

1. Nag S., Beyer D., Friedland J., et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999, 44:789-799.
2. Crook J.M., Potters L., Stock R.G., et al. Critical organ dosimetry in permanent seed prostate brachytherapy: Defining the organs at risk. Brachytherapy 2005, 4:186-194.
3. Eshleman J.S., Davis B.J., Pisansky T.M., et al. Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: Extraprostatic seed placement correlates with migration. Int J Radiat Oncol Biol Phys 2004, 59:419-425.
4. Merrick G.S., Butler W.M., Dorsey A.T., et al. Seed fixity in the prostate/periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys 2000, 46:215-220.
5. Spadinger I., Hilts M., Keyes M., et al. Prostate brachytherapy postimplant dosimetry: A comparison of suture-embedded and loose seed implants. Brachytherapy 2006, 5:165-173.
6. Steinfeld A.D., Donahue B.R., Plaine L. Pulmonary embolization of iodine-125 seeds following prostate implantation. Urology 1991, 37:149-150.
7. Nag S., Scaperoth D.D., Badalament R., et al. Transperineal palladium 103 prostate brachytherapy: Analysis of morbidity and seed migration. Urology 1995, 45:87-92.
8. Fuller D.B., Koziol J.A., Feng A.C. Prostate brachytherapy seed migration and dosimetry: Analysis of stranded sources and other potential predictive factors. Brachytherapy 2004, 3:10-19.
9. Pinkawa M., Asadpour B., Gagel B., et al. Evaluation of source displacement and dose-volume changes after permanent prostate brachytherapy with stranded seeds. Radiother Oncol 2007, 84:190-196.
10. Saibishkumar E.P., Borg J., Yeung I., et al. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 2009, 73:61-68.
11. McLaughlin P., Narayana V., Pan C., et al. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds. Int J Radiat Oncol Biol Phys 2006, 64:144-150.
12. Kupelian P.A., Willoughby T.R., Meeks S.L., et al. Intraprostatic fiducials for localization of the prostate gland: Monitoring intermarker distances during radiation therapy to test for marker stability. Int J Radiat Oncol Biol Phys 2005, 62:1291-1296.
13. Schallenkamp J.M., Herman M.G., Kruse J.J., et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 2005, 63:800-811.
14. Morris W.J., Keyes M., Palma D., et al. Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 2009, 73:1432-1438.
15. Keyes M., Miller S., Moravan V., et al. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: Long-term outcome in 712 consecutive patients. Int J Radiat Oncol Biol Phys 2009, 73:1023-1032.
16. Morris W.J., Keyes M., Palma D., et al. Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer. Urology 2009, 73:860-865.
17. Chng N, Spadinger I, Morris WJ, et al. Automatic plan reconstruction of stranded implants. Med Phys. In press.
18. Potters L., Calguaru E., Thornton K.B., et al. Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodology. Brachytherapy 2003, 2:172-180.
19. Kaplan I.D., Meskell P.M., Lieberfarb M., et al. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: A randomized trial. Brachytherapy 2004, 3:7-9.
20. Roberson P.L., Narayana V., McShan D.L., et al. Source placement error for permanent implant of the prostate. Med Phys 1997, 24:251-257.
21. Waterman F.M., Dicker A.P. Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: Can implant quality be predicted on day 0?. Int J Radiat Oncol Biol Phys 2002, 53:610-621.
22. Usmani N., Sloboda R., Kamal W., et al. Can images obtained with high field strength MRI reduce contouring variability of the prostate?. Int J Radiat Oncol Biol Phys 2010, [Epub ahead of print].
23. Sloboda R., Usmani N., Pedersen J., et al. Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging. Brachytherapy 2010, 9:354-361.
24. Dehnad H., Nederveen A.J., van der Heide U.A., et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 2003, 67:295-302.
25. Poggi M.M., Gant D.A., Sewchand W., et al. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys 2003, 56:1248-1251.
26. Pouliot J., Aubin M., Langen K.M., et al. (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. Int J Radiat Oncol Biol Phys 2003, 56:862-866.